BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical
June 23, 2022 07:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, June 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT), has launched its advanced proprietary supplement for dogs, Canine All-in-One, a daily dose...
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD
June 09, 2022 07:00 ET
|
BioAdaptives, Inc.
Management Pursues Growth By Bringing Advanced Wellness Through Advantageous Senior Pricing LAS VEGAS, NV, June 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT). ...
BioAdaptives Sponsors COVID-19 Long Hauler Survey
June 02, 2022 07:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, June 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announces its sponsorship of the COVID Long Haul Survey conducted by independent medical...
BioAdaptives Expands Gadolinium Deposition Disease Survey
February 25, 2022 10:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, Feb. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT), In reference to the previous Press Release of February 24, 2022, the Company announced today...
BioAdaptives Announces Initial Investigation Results Pluripain® Improves Symptoms of Gadolinium Deposition Disease
February 24, 2022 07:00 ET
|
BioAdaptives, Inc.
LAS VEGAS, NV, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today positive results from a study conducted by Stanford Medical School Professor,...
BioAdaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products
February 03, 2022 07:00 ET
|
BioAdaptives, Inc.
Company closes on Patented Technology acquisition; plans new products through wholly-owned subsidiary Las Vegas, Nevada, Feb. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc....
BioAdaptives to Investigate Use of Lung Cleanser for Long-Term Smokers
January 27, 2022 06:30 ET
|
BioAdaptives, Inc.
Company to study OSCPeP device usage for active smokers and second-hand exposure Las Vegas, Nevada, Jan. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT)...
BioAdaptives Signs Letter of Intent to Acquire Oxygenated Water Technology Patent
January 20, 2022 06:30 ET
|
BioAdaptives, Inc.
BioAdaptives to Acquire T J Mohr Patents and Other Potential Inventions LAS VEGAS, NV, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today that...
BioAdaptives' LungFlute Marketing Agreement and New Product
December 15, 2021 06:30 ET
|
BioAdaptives, Inc.
Las Vegas, NV, Dec. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced that it has entered into a Marketing Agreement with Acoustic Innovations LLC, the...
BioAdaptives Collaboration with Stanford Professor
August 26, 2021 07:00 ET
|
BioAdaptives, Inc.
PluriPain studied for pain relief in Gadolinium toxicity patients Las Vegas, Nevada, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced the...